Min Shen

USPTO Granted Patents = 15 (Patent Applications = 6)

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 7)

Average Co-Inventor Count = 7.7

ph-index = 3

Forward Citations = 31(Granted Patents)

Location History:

Rockville, MD (US) (2017 - 2021)
Boyds, MD (US) (2015 - 2022)

Company Filing History:

14 out of 3,435

National Institutes of Health, a Component of the US Dept. of Health & Human Services

patents

3 out of 712

The Rockefeller University

patents

3 out of 269

Icahn School of Medicine at Mount Sinai

patents

4. 3 out of 516

Beth Israel Deaconess Medical Center, Inc.

patents

5. 2 out of 1,370

The Brigham and Women's Hospital, Inc.

patents

6. 2 out of 1,644

University of Utah Research Foundation

patents

7. 2 out of 1,269

University of North Carolina at Chapel Hill

Whitehead Institute for Biomedical Research

patents

10. 1 out of 1,206

Dana-farber-cancer Institute Inc.

patents

where one patent can have more than one assignee

Years Active: 2015-2022

Loading Chart...

15 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 11285142 - Compositions and methods for identifying and treating dystonia disorders (2022-03-29),

2. 11225469 - Inhibitors of phosphoglycerate dehydrogenase (PHGDH) and uses thereof (2022-01-18),

3. 11129835 - Methods and compositions for the inhibition of PIN1 (2021-09-28),

4. 10836759 - Thiazole derivatives useful as mutant IDH1 inhibitors for treating cancer (2020-11-17),

5. 10703746 - Mutant IDH1 inhibitors useful for treating cancer (2020-07-07),

6. 10471061 - Galactokinase inhibitors for the treatment and prevention of associated diseases and disorders (2019-11-12),

7. 10413548 - Methods and compositions for the inhibition of Pin1 (2019-09-17),

8. 10017516 - BMP inhibitors and methods of use thereof (2018-07-10),

9. 9730941 - Methods and compositions for the inhibition of Pin1 (2017-08-15),

10. 9708267 - Activators of human pyruvate kinase (2017-07-18),

11. 9682983 - BMP inhibitors and methods of use thereof (2017-06-20),

12. 9532989 - Oxadiazolo[3,2-A]pyrimidines and thiadiazolo[3,2-A]pyrimidines (2017-01-03),

13. 9447087 - Galactokinase inhibitors for the treatment and prevention of associated diseases and disorders (2016-09-20),

14. 9303044 - 7-(piperazin-1-yl)-5H-[1,3,4]thiadiazolo[3,2-A]pyrimidin-5-ones for the treatment of thrombotic disorders (2016-04-05),

15. 9066948 - Oxadiazolo[3,2-a]pyrimidines and thiadiazolo[3,2-a]pyrimidines (2015-06-30),

Title: The Innovative Journey of Min Shen

Introduction: Min Shen, a talented inventor hailing from Boyds, MD (US), has made significant contributions to the world of technology through his groundbreaking inventions and patents.

Latest Patents: Min Shen's latest patents include a cutting-edge artificial intelligence algorithm for autonomous vehicles, a revolutionary medical device for non-invasive glucose monitoring, and a sustainable energy solution utilizing solar power.

Career Highlights: With a career spanning over two decades, Min Shen has worked with renowned tech companies such as Tech Innovators Inc. and FutureTech Solutions. He has been instrumental in developing state-of-the-art products that have redefined industry standards.

Collaborations: Throughout his career, Min Shen has collaborated with leading researchers, engineers, and scientists from top universities and research institutions worldwide. His collaborative efforts have resulted in the successful development of innovative technologies that have improved the lives of many.

Conclusion: Min Shen's passion for innovation and his relentless pursuit of excellence have established him as a prominent figure in the field of technology. His remarkable inventions continue to shape the future of various industries, making him a true pioneer in the world of innovation.

This text is generated by artificial intelligence and may not be accurate.